tci Part B Insider - 2003 Issue 28

New Alzheimer's Drug Approved

There's a new treatment option for people with advanced Alzheimer's disease. The U.S. Food and Drug Administration on Friday gave its approval to memantine, which has long been sold in Europe. "The approval of memantine is good news for Alzheimer's disease patients," said FDA Commissioner Dr. Mark McClellan. "This is the first drug shown to have an effect on the symptoms of moderate to severe Alzheimer's disease, and shows a low incidence of minor side effects." Forest Laboratories will sell the drug in the United States under the brand name Namenda. For more details on...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.